Calcium
Control (Usual Activity) → Calcium
Control (Usual Activity) → Calcium
Evidence profile
Key finding
Inulin-type fructans did not significantly affect serum concentrations of calcium (0.05 ± 0.02 mmol/L vs. 0.02 ± 0.03 mmol/L, p = 0.324).
This study investigated the effects of inulin-type fructans on serum levels of calcium, magnesium, and vitamin D in individuals with type 2 diabetes, finding no significant improvements.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Inulin-type fructans, Control supplement (maltodextrin)
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Primary outcome
Serum calcium
Comparator
Control supplement (maltodextrin)
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study investigated the effects of inulin-type fructans on serum levels of calcium, magnesium, and vitamin D in individuals with type 2 diabetes, finding no significant improvements.
Understanding the effects of dietary supplements like inulin-type fructans on nutrient levels is crucial for managing type 2 diabetes. Since the study showed no significant improvements in serum calcium, magnesium, or vitamin D, it suggests that healthcare providers may need to consider alternative strategies to manage these nutrient levels in diabetic patients.
The study may have a limited sample size affecting generalizability. The duration of the intervention may not have been sufficient to observe changes. Potential confounding factors were not fully controlled.
Published in
Publication details and source links for this paper.
Eline B, Wuraola AB, Kristine DM, et al. Inulin-type fructans did not improve serum levels of calcium, magnesium, or vitamin D in people with T2D. Archives of Osteoporosis. 2025;20(1):71. doi:10.1007/s11657-025-01556-x
Save this study and add notes to your research library.
Inulin-type fructans did not significantly affect serum calcium levels (0.05 mmol/L vs. 0.02 mmol/L, p = 0.324).
Inulin-type fructans did not significantly affect serum magnesium levels (0.02 mmol/L vs. 0.00 mmol/L, p = 0.352).
Inulin-type fructans did not significantly affect serum 25(OH) vitamin D levels (-3.60 nmol/L vs. -2.00 nmol/L, p = 0.564).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Control (Usual Activity), Inulin-type fructans and Calcium, Serum 25-hydroxyvitamin D, Serum CTX-1, and 2 more.
This study contributes evidence to
Primary intervention
Control (Usual Activity)
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
1
Related topics
10
Evidence pairs
14
Related studies
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Control (Usual Activity) → Calcium
Control (Usual Activity) → Calcium
Evidence profile
Control (Usual Activity) → Serum 25-hydroxyvitamin D
Control (Usual Activity) → Serum 25-hydroxyvitamin D
Evidence profile
Control (Usual Activity) → Serum CTX-1
Control (Usual Activity) → Serum CTX-1
Evidence profile
Control (Usual Activity) → Serum magnesium
Control (Usual Activity) → Serum magnesium
Evidence profile
Control (Usual Activity) → Serum P1NP
Control (Usual Activity) → Serum P1NP
Evidence profile
Inulin-type fructans → Calcium
Inulin-type fructans → Calcium
Evidence profile
Inulin-type fructans → Serum 25-hydroxyvitamin D
Inulin-type fructans → Serum 25-hydroxyvitamin D
Evidence profile
Inulin-type fructans → Serum CTX-1
Inulin-type fructans → Serum CTX-1
Evidence profile
Inulin-type fructans → Serum magnesium
Inulin-type fructans → Serum magnesium
Evidence profile
Inulin-type fructans → Serum P1NP
Inulin-type fructans → Serum P1NP
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Generated from the study's connected evidence using Evidence Intelligence™.
Current evidence does not show a clear benefit of Probiotics and Synbiotics for Kidney Function.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Serum CTX-1
EvidenceScore™ Limited | EvidenceScore™ 29.1 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Current evidence does not show a clear benefit of Probiotics and Synbiotics for Adipokine and Angiogenic Markers.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Serum 25-hydroxyvitamin D
EvidenceScore™ Limited | EvidenceScore™ 29.1 | neutral | ConsensusScore™ Unclear | 1 study
Serum magnesium
EvidenceScore™ Limited | EvidenceScore™ 29.1 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 9 supporting studies and existing graph evidence signals.
Limitations
Current evidence does not show a clear benefit of Control (Usual Activity) for Calcium.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Calcium
EvidenceScore™ Limited | EvidenceScore™ 29.1 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Control (Usual Activity) for Serum 25-hydroxyvitamin D.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Serum 25-hydroxyvitamin D
EvidenceScore™ Limited | EvidenceScore™ 29.1 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.